Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 1294 entries
View as:

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01513525 Org: User:
Start: 02/28/07 End: 05/31/07 Due: 05/31/08

Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01892020 Org: User:
Start: 06/30/13 End: 05/31/14 Due: 05/31/15

Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00787878 Org: User:
Start: 02/28/09 End: 01/31/11 Due: 01/31/12

A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01618188 Org: User:
Start: 06/11/12 End: 09/07/12 Due: 09/07/13

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01486901 Org: User:
Start: 05/31/06 End: 07/31/06 Due: 07/31/07

A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)

Phase: N/A Priority: Normal
NCT ID: NCT06269107 Org: User:
Start: 02/15/24 End: 06/30/25 Due: 06/30/26

First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects

Phase: N/A Priority: Normal
NCT ID: NCT01261767 Org: User:
Start: 04/30/08 End: 01/31/11 Due: 01/31/12

A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00976326 Org: User:
Start: 08/31/09 End: 03/31/10 Due: 03/31/11

Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Phase: N/A Priority: Normal
NCT ID: NCT01530048 Org: User:
Start: 03/31/06 End: 05/31/06 Due: 05/31/07

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II

Phase: N/A Priority: Normal
NCT ID: NCT05333107 Org: User:
Start: 04/12/22 End: 09/23/22 Due: 09/23/23

A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02035371 Org: User:
Start: 01/13/14 End: 07/24/14 Due: 07/24/15

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01542424 Org: User:
Start: 03/31/06 End: 12/31/06 Due: 12/31/07

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00627445 Org: User:
Start: 02/29/08 End: 01/31/09 Due: 01/31/10

Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02079870 Org: User:
Start: 03/06/14 End: 01/07/15 Due: 01/07/16

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT03819153 Org: User:
Start: 06/17/19 End: 01/09/24 Due: 01/09/25

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05478252 Org: User:
Start: 08/03/22 End: 09/18/23 Due: 09/18/24

An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries

Phase: N/A Priority: Normal
NCT ID: NCT00842192 Org: User:
Start: 04/30/09 End: 08/31/10 Due: 08/31/11

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02827708 Org: User:
Start: 09/20/16 End: 05/15/18 Due: 05/15/19

A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT03707990 Org: User:
Start: 10/15/18 End: 08/13/19 Due: 08/13/20

Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01545791 Org: User:
Start: 05/31/06 End: 02/29/08 Due: 02/28/09

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01509742 Org: User:
Start: 04/30/01 End: 11/30/01 Due: 11/30/02

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02148861 Org: User:
Start: 05/26/14 End: 06/01/15 Due: 06/01/16

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01077570 Org: User:
Start: 03/31/10 End: 02/28/11 Due: 02/28/12

Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens)

Phase: N/A Priority: Normal
NCT ID: NCT05013359 Org: User:
Start: 08/23/21 End: 12/13/21 Due: 12/13/22

Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01512095 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14